Pharma Firms Reject Anthropic's Data Requests, Making Data the Moat for AI Drug Discovery
Hesamation · x · 2026-07-07
A blogger pointed out that Anthropic was unanimously rejected by major pharmaceutical companies when requesting data, arguing this is a primary reason why AI has triumphed in software but has yet to make major scientific discoveries.
The analysis suggests pharma companies recognize data as their moat and refuse to hand it over. The blogger further predicts more companies will realize this and turn to open-source solutions to 'own their weights'.
Related event: Anthropic Denied Data Access by Big Pharma(2 posts)→
More from Companies & People
- Microsoft India offers voluntary exit to employees at level 70 and below: 1 month pay per year + 3 months — HarveenChadha · 2026-10-27
- RSNA 2026 Deep Learning Labs return: eight hands-on AI classes over four days in Chicago — PRouzrokh · 2026-10-27
- Zuckerberg says Apple stopped innovating; Kuprel: it also missed AI smart glasses — Kuprel · 2026-10-27
- Revolut founder Storonsky: investor pushed me to fire my best engineer, so I removed all VCs from the board — ctjlewis · 2026-10-27
- Ortet, a new AI healthcare startup, runs on its own cluster Orion and seeks partners — keunwoochoi · 2026-10-27
- Embodied AI startups need a different operational discipline, investor says — ___Mufasaa · 2026-10-27